Highlights of ASH in North America

Registration is closed!

Thank you for joining the world's leading hematology experts at Highlights of ASH in North America. Complete the meeting evaluation survey, claim CME/ABIM MOC, and print/save your CME certificate below.

claim cme/moc certificate

About Highlights of ASH in North America

By attending Highlights of ASH, you will get a comprehensive review of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into cutting-edge patient care.

Throughout this meeting, you will be able to:

Blood icon

Access a program curated from highlights of the ASH annual meeting which covers the latest and most influential topics in hematology.

icon for engage interaction-an avatar looking at the screen

Engage in interactive panel discussions with speakers and attend small group lunch sessions with experts in the field.

An icon for a group of experts

Network with experts, exhibitors, and peers in a close-knit setting.

A calendar icon for scheduling events

Choose from several dates and locations to best meet your schedule.

View Program Information

Program Schedule

The program schedule below is identical for all 2025 Highlights of ASH in North America locations. The following information is preliminary and subject to change.

Close All Open All

11:00 a.m.	Registration and Exhibits Open (Lunch provided)
11:45 p.m.	Welcome and Introductions
12:00 p.m.	*When It Rains It Pours: Hemophilia Treatment in an Age of Plenty*
	Tyler Buckner, MD, MSc University of Colorado	Seattle, WA
	Patrick Ellsworth, MD University of North Carolina	New York, NY Chicago, IL
	Ayesha Zia, MD, MSc University of Texas Southwestern	Washington, DC
12:45 p.m.	*Transfusion Medicine*
	Grace Lee, MD Duke University	Chicago, IL
	Katerina Pavenski, MD, FRCPC University of Toronto	Seattle, WA Washington, DC
	Michelle Zeller, MD, MHPE, FRCPC, DRCPSC McMaster University	New York, NY
1:30 p.m.	*Updates on Current, Emerging, and Curative Therapies for Sickle Cell Disease*
	Maureen Okam Achebe, MD, MPH Brigham and Women's Hospital	New York, NY
	Cecelia Calhoun, MD, MPHS, MBA Yale University	Seattle, WA Chicago, IL
	Rakhi Naik, MD, MS Johns Hopkins University	Washington, DC
2:15 p.m.	Panel Discussion
2:45 p.m.	Coffee Break and Exhibits Open
3:00 p.m.	ALL Updates from ASH: First-Line Targeted Therapy in Ph- and Ph+ ALL and a New CAR-T!
	Patrick Burke, MD University of Michigan	Seattle, WA
	Adam Duvall, MD, MPH University of Chicago	Chicago, IL
	Ryan Mattison, MD University of Wisconsin	New York, NY Washington, DC
3:45 p.m.	*Innovations in Multiple Myeloma and Plasma Cell Dyscrasias: Charting the Path Forward*
	Susan Bal, MD University of Alabama at Birmingham	New York, NY
	Doris Hansen, MD Moffitt Cancer Center	Chicago, IL
	Jonathan Kaufman, MD Emory University	Seattle, WA Washington, DC
4:30 p.m.	*Acute Myeloid Leukemia*
	Courtney DiNardo, MD Anderson Cancer Center	Washington, DC
	Charles Foucar, MD University of New Mexico	Chicago, IL
	Catherine Lai, MD, MPH University of Pennsylvania	Seattle, WA
	Jerald Radich, MD Fred Hutchinson Cancer Center	New York, NY
5:15 p.m.	Panel Discussion
5:45 p.m.	Highlights of ASH Day 1 Program Adjournment

7:00 a.m.	Registration and Exhibits Open (Breakfast provided)
7:45 a.m.	Welcome and Introductions
8:00 a.m.	A Day in the Life of a Shematologist: Exploring the Intersection of Hematology and Women's Health
	Sarah H. O'Brien, MD, MSc Nationwide Children's	New York, NY Washington, DC
	Menaka Pai, MD, MSc, FRCPC McMaster University	Chicago, IL
	Bethany Samuelson Bannow, MD Oregon Health and Science University Medicine	Seattle, WA
8:45 a.m.	Clinical Applications of Health Outcomes Research for Blood Cancers
	Pamela Egan, MD Maine Health	Washington, DC
	Areej El-Jawahri, MD Massachusetts General Hospital	Seattle, WA
	Thomas W. LeBlanc, MD, MA, MHS Duke University	New York, NY Chicago, IL
9:30 a.m.	Consultative Hematology: What Are My Other Options?
	Cyrus Hsia, MD, FRCPC Western University	New York, NY
	Jacquelyn M. Powers, MD, MS Texas Children’s Hospital	Chicago, IL
	Joseph Shatzel, MD, MCR Oregon Health and Science University Medicine	Seattle, WA Washington, DC
10:15 a.m.	Panel Discussion
10:45 a.m.	Coffee Break and Exhibits Open
11:00 a.m.	Myelodysplastic Syndromes and Clonal Hematopoiesis
	Guillermo Garcia-Manero, MD MD Anderson Cancer Center	Chicago, IL
	Morgan Jones, MD, PhD University of Michigan	New York, NY Washington, DC
	Afaf Osman, MD University of Utah	Seattle, WA
11:45 a.m.	Moving the Needle in the Treatment of Myeloproliferative Neoplasms and Chronic Myeloid Leukemia
	Chi-Joan How, MD Brigham and Women’s Hospital	Washington, DC
	Andrew Kuykendall, MD Moffitt Cancer Center	Seattle, WA
	Kristen Pettit, MD University of Michigan	Chicago, IL
	Douglas Tremblay, MD Mount Sinai	New York, NY
12:30 p.m.	Panel Discussion
1:00 p.m.	Lunch with the Experts (All Speakers and Attendees)
2:15 p.m.	Clinical Insights in Transplantation
	Ran Reshef, MD, MSc Columbia University Irving Medical Center	New York, NY
	Bart L. Scott, MD Fred Hutchinson Cancer Center	Seattle, WA Washington, DC
	Melody Smith, MD, MS Stanford University	Chicago, IL
3:00 p.m.	*Highlights in Aggressive Lymphoma and Hodgkin Lymphomas*
	Paul Barr, MD University of Rochester	Seattle, WA
	Carla Casulo, MD University of Rochester	Chicago, IL
	Manali Kamdar, MD University of Colorado	Washington, DC
	Sarah Rutherford, MD Weill Cornell Medicine	New York, NY
3:45 p.m.	*The Evolving Role of Targeted and Immunotherapy in Indolent Lymphoma and Chronic Lymphocytic Leukemia*
	Alexey Danilov, MD, PhD City of Hope National Medical Center	Seattle, WA
	Jia Ruan, MD, PhD Weill Cornell Medicine	New York, NY Washington, DC
	Deborah Stephens, DO University of North Carolina	Chicago, IL
4:30 p.m.	Panel Discussion
5:00 p.m.	Closing Remarks and Adjournment

View Faculty Disclosure Information

Acknowledgements

Thank you to our esteemed committee of experts dedicated to advancing the development of this meeting, and our company partners for providing educational grants in support of the 2025 Highlights of ASH in North America

Jia Ruan, MD, PhD, Chair, Weill Cornell Medicine
Tyler Buckner, MD, MSc, University of Colorado Denver
Pamela Egan, MD, Maine Health
Manali Kamdar, MD, University of Colorado
Jonathan L. Kaufman, MD, Emory University
Rakhi Naik, MD, MHS, Johns Hopkins University
Kristen Pettit, MD, University of Michigan
Eric Tse, PhD, MBBS, Hong Kong University
Michelle Zeller, MD, McMaster University